Product Code: PM2299
The global multiplex assays market size is expected to reach USD 5.57 billion by 2030, according to a new study by Polaris Market Research. The report "Multiplex Assays Market Share, Size, Trends, Industry Analysis Report, By Technology; By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays, Cell-Based Multiplex Assays); By Application, By End-User; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The key factors driving the market's growth include adopting multiplex assays across various verticals such as health services and others. Due to the growing use of customized treatment and benefits over standard tests, the market is expected to rise rapidly. Medical science, which has gained popularity in recent years, strives to provide individual patients with tailored therapies based on the molecular foundation of their disease.
Based on the type, the nucleic acid segment accounted for the leading share in the industry in 2021. This is due to the rising use of nucleic acids, ease of configuration to detect practically any target, low sample volume requirements, and level of automation to be achieved. A rise in the use of molecular diagnostic tests developed to diagnose diseases, such as human genetic markers, such as cancer, and genetic markers for disease predisposition also contributes to the economic development of the nucleic acid-based segment.
Market players such as Luminex Corporation, Enzo Life Sciences, Inc., Promega Corporation, Meso Scale Diagnostics, Quanterix, Thermo Fisher Scientific Inc., Qiagen N.V., Illumina, Inc, Shimadzu Biotech, Abcam plc, Bio-Rad Laboratories, Inc., Becton Dickinson and Company, Randox Laboratories, Merck KGaA, Agilent Technologies, Inc., Olink, DiaSorin S.p.A., Antigenix America, Inc., Siemens Healthineers, PerkinElmer, Inc., Boster Biological Technology, Seegene, and Cayman Chemical Company are some key players operating in the global market.
In August 2021, The BD COR System, a new automated diagnostic system from Becton, Dickinson, and Company, was released. In centralized laboratories across the U.S., the system uses robots and sample management software algorithms for genetic disease testing. Thus, the development of new technologies by major players and adoption of them across various laboratories is boosting the market growth during the forecast period.
Polaris Market Research has segmented the multiplex assays market report based on type, technology, application, end-user, and region:
Multiplex assays, Type Outlook (Revenue - USD Billion, 2018 - 2030)
Protein
Planar Protein
Bead-Based Protein
Other Protein
Nucleic Acid
Planar Nucleic Acid
Bead-Based Nucleic Acid
Other Nucleic Acid
Cell-Based
Multiplex assays, Technology Outlook (Revenue - USD Billion, 2018 - 2030)
Flow Cytometry
Fluorescence Detection
Luminescence
Multiplex Real-Time PCR
Other Technologies
Multiplex assays, Application Outlook (Revenue - USD Billion, 2018 - 2030)
Research & Development
Drug Discovery & Development
Biomarker Discovery & Validation
Clinical Diagnostics
Infectious Diseases
Cancer
Cardiovascular Diseases
Autoimmune Diseases
Nervous System Disorders
Metabolism & Endocrinology Disorders
Others
Multiplex assays, End-User Outlook (Revenue - USD Billion, 2018 - 2030)
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Others
Multiplex assays, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Austria
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Multiplex Assays Market Insights
- 4.1. Multiplex Assays - Industry Snapshot
- 4.2. Multiplex Assays Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing use of multiplex assays in companion diagnostics
- 4.2.1.2. Increasing validation of the biomarkers in molecular and protein diagnostics
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Increasing cost of the equipment and increasingly stringent regulation and standards
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Multiplex Assays Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Multiplex Assays Market, by Application
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 5.3. Research & Development
- 5.3.1. Global Multiplex Assays Market, by Research & Development, by Region, 2018 - 2030 (USD Billion)
- 5.3.2. Drug Discovery & Development
- 5.3.2.1. Global Multiplex Assays Market, by Drug Discovery & Development, by Region, 2018 - 2030 (USD Billion)
- 5.3.3. Biomarker Discovery & Validation
- 5.3.3.1. Global Multiplex Assays Market, by Biomarker Discovery & Validation, by Region, 2018 - 2030 (USD Billion)
- 5.4. Clinical Diagnostics
- 5.4.1. Global Multiplex Assays Market, by Clinical Diagnostics, by Region, 2018 - 2030 (USD Billion)
- 5.4.2. Cancer
- 5.4.2.1. Global Multiplex Assays Market, by Cancer, by Region, 2018 - 2030 (USD Billion)
- 5.4.3. Cardiovascular Diseases
- 5.4.3.1. Global Multiplex Assays Market, by Cardiovascular Diseases, by Region, 2018 - 2030 (USD Billion)
- 5.4.4. Autoimmune Diseases
- 5.4.4.1. Global Multiplex Assays Market, by Autoimmune Diseases, by Region, 2018 - 2030 (USD Billion)
- 5.4.5. Nervous System Disorders
- 5.4.5.1. Global Multiplex Assays Market, by Nervous System Disorders, by Region, 2018 - 2030 (USD Billion)
- 5.4.6. Metabolism & Endocrinology Disorders
- 5.4.6.1. Global Multiplex Assays Market, by Metabolism & Endocrinology Disorders, by Region, 2018 - 2030 (USD Billion)
- 5.4.7. Others
- 5.4.7.1. Global Multiplex Assays Market, by Others, by Region, 2018 - 2030 (USD Billion)
6. Global Multiplex Assays Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 6.3. Protein Multiplex Assays
- 6.3.1. Global Multiplex Assays Market, by Protein Multiplex Assays, by Region, 2018 - 2030 (USD Billion)
- 6.3.2. Planar Protein Assays
- 6.3.2.1. Global Multiplex Assays Market, by Planar Protein Assays, by Region, 2018 - 2030 (USD Billion)
- 6.3.3. Bead-Based Protein Assays
- 6.3.3.1. Global Multiplex Assays Market, by Bead-Based Protein Assays, by Region, 2018 - 2030 (USD Billion)
- 6.3.4. Other Protein Assays
- 6.3.4.1. Global Multiplex Assays Market, by Other Protein Assays, by Region, 2018 - 2030 (USD Billion)
- 6.4. Nucleic Acid Multiplex Assays
- 6.4.1. Global Multiplex Assays Market, by Nucleic Acid Multiplex Assays, by Region, 2018 - 2030 (USD Billion)
- 6.4.2. Planar Nucleic Acid Assays
- 6.4.2.1. Global Multiplex Assays Market, by Planar Nucleic Acid Assays, by Region, 2018 - 2030 (USD Billion)
- 6.4.3. Bead-Based Nucleic Acid Assays
- 6.4.3.1. Global Multiplex Assays Market, by Bead-Based Nucleic Acid Assay, by Region, 2018 - 2030 (USD Billion)
- 6.4.4. Other Nucleic Acid Assays
- 6.4.4.1. Global Multiplex Assays Market, by Other Nucleic Acid Assays, by Region, 2018 - 2030 (USD Billion)
- 6.5. Cell-Based Multiplex Assays
- 6.5.1. Global Multiplex Assays Market, by Cell-Based Multiplex Assays, by Region, 2018 - 2030 (USD Billion)
7. Global Multiplex Assays Market, by Technology
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 7.3. Flow Cytometry
- 7.3.1. Global Multiplex Assays Market, by Flow Cytometry, by Region, 2018 - 2030 (USD Billion)
- 7.4. Fluorescence Detection
- 7.4.1. Global Multiplex Assays Market, by Fluorescence Detection, by Region, 2018 - 2030 (USD Billion)
- 7.5. Luminescence
- 7.5.1. Global Multiplex Assays Market, by Luminescence, by Region, 2018 - 2030 (USD Billion)
- 7.6. Multiplex Real-Time PCR
- 7.6.1. Global Multiplex Assays Market, by Multiplex Real-Time PCR, by Region, 2018 - 2030 (USD Billion)
- 7.7. Others
- 7.7.1. Global Multiplex Assays Market, by Others, by Region, 2018 - 2030 (USD Billion)
8. Global Multiplex Assays Market, by End-User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 8.3. Pharmaceutical & Biotechnology Companies
- 8.3.1. Global Multiplex Assays Market, by Pharmaceutical & Biotechnology Companies, by Region, 2018 - 2030 (USD Billion)
- 8.4. Hospitals & Research Institutes
- 8.4.1. Global Multiplex Assays Market, by Hospitals & Research Institutes, by Region, 2018 - 2030 (USD Billion)
- 8.5. Reference Laboratories
- 8.5.1. Global Multiplex Assays Market, by Reference Laboratories, by Region, 2018 - 2030 (USD Billion)
- 8.6. Others
- 8.6.1. Global Multiplex Assays Market, by Others, by Region, 2018 - 2030 (USD Billion)
9. Global Multiplex Assays Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Multiplex Assays Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 9.3. Multiplex Assays Market - North America
- 9.3.1. North America: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.3.2. North America: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.3.3. North America: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.3.4. North America: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.3.5. Multiplex Assays Market - U.S.
- 9.3.5.1. U.S.: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.3.5.2. U.S.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.3.5.3. U.S.: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.3.5.4. U.S.: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.3.6. Multiplex Assays Market - Canada
- 9.3.6.1. Canada: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.3.6.2. Canada: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.3.6.3. Canada: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.3.6.4. Canada: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4. Multiplex Assays Market - Europe
- 9.4.1. Europe: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.2. Europe: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.3. Europe: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.4. Europe: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.5. Multiplex Assays Market - UK
- 9.4.5.1. UK: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.5.2. UK: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.5.3. UK: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.5.4. UK: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.6. Multiplex Assays Market - France
- 9.4.6.1. France: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.6.2. France: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.6.3. France: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.6.4. France: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.7. Multiplex Assays Market - Germany
- 9.4.7.1. Germany: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.7.2. Germany: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.7.3. Germany: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.7.4. Germany: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.8. Multiplex Assays Market - Italy
- 9.4.8.1. Italy: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.8.2. Italy: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.8.3. Italy: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.8.4. Italy: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.9. Multiplex Assays Market - Spain
- 9.4.9.1. Spain: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.9.2. Spain: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.9.3. Spain: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.9.4. Spain: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.10. Multiplex Assays Market - Netherlands
- 9.4.10.1. Netherlands: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.10.2. Netherlands: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.10.3. Netherlands: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.10.4. Netherlands: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.11. Multiplex Assays Market - Austria
- 9.4.11.1. Austria: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.11.2. Austria.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.11.3. Austria: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.11.4. Austria: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5. Multiplex Assays Market - Asia Pacific
- 9.5.1. Asia Pacific: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.2. Asia Pacific: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.3. Asia Pacific: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.4. Asia Pacific: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.5. Multiplex Assays Market - China
- 9.5.5.1. China: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.5.2. China.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.5.3. China: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.5.4. China: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.6. Multiplex Assays Market - India
- 9.5.6.1. India: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.6.2. India.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.6.3. India: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.6.4. India: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.7. Multiplex Assays Market - Japan
- 9.5.7.1. Japan: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.7.2. Japan.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.7.3. Japan: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.7.4. Japan: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.8. Multiplex Assays Market - Malaysia
- 9.5.8.1. Malaysia: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.8.2. Malaysia.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.8.3. Malaysia: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.8.4. Malaysia: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.9. Multiplex Assays Market - Indonesia
- 9.5.9.1. Indonesia: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.9.2. Indonesia.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.9.3. Indonesia: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.9.4. Indonesia: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.10. Multiplex Assays Market - South Korea
- 9.5.10.1. South Korea: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.10.2. South Korea.: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.10.3. South Korea: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.10.4. South Korea: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6. Multiplex Assays Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.2. Middle East & Africa: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.3. Middle East & Africa: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.4. Middle East & Africa: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.5. Multiplex Assays Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.5.2. Saudi Arabia: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.5.3. Saudi Arabia: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.5.4. Saudi Arabia: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.6. Multiplex Assays Market - South Africa
- 9.6.6.1. South Africa: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.6.2. South Africa: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.6.3. South Africa: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.6.4. South Africa: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.7. Multiplex Assays Market - Israel
- 9.6.7.1. Israel: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.7.2. Israel: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.7.3. Israel: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.7.4. Israel: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.8. Multiplex Assays Market - UAE
- 9.6.8.1. UAE: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.8.2. UAE: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.8.3. UAE: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.8.4. UAE: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7. Multiplex Assays Market - Latin America
- 9.7.1. Latin America: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.7.2. Latin America: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.3. Latin America: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.7.4. Latin America: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7.5. Multiplex Assays Market - Mexico
- 9.7.5.1. Mexico: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.7.5.2. Mexico: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.5.3. Mexico: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.7.5.4. Mexico: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7.6. Multiplex Assays Market - Brazil
- 9.7.6.1. Brazil: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.7.6.2. Brazil: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.6.3. Brazil: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.7.6.4. Brazil: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7.7. Multiplex Assays Market - Argentina
- 9.7.7.1. Argentina: Multiplex Assays Market, by Application, 2018 - 2030 (USD Billion)
- 9.7.7.2. Argentina: Multiplex Assays Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.7.3. Argentina: Multiplex Assays Market, by Type, 2018 - 2030 (USD Billion)
- 9.7.7.4. Argentina: Multiplex Assays Market, by Technology, 2018 - 2030 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Luminex Corporation
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Enzo Life Sciences, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Promega Corporation
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Meso Scale Diagnostics
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Quanterix
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Thermo Fisher Scientific Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Qiagen N.V
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Illumina, Inc.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Shimadzu Biotech
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Abcam plc
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Bio-Rad Laboratories, Inc.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Becton
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. AYOXXA Biosystems GmbH
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Bio-Techne Corporation
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Dickinson and Company
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
- 11.16. Randox Laboratories
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development
- 11.17. Merck KGaA
- 11.17.1. Company Overview
- 11.17.2. Financial Performance
- 11.17.3. Product Benchmarking
- 11.17.4. Recent Development
- 11.18. Agilent Technologies, Inc.
- 11.18.1. Company Overview
- 11.18.2. Financial Performance
- 11.18.3. Product Benchmarking
- 11.18.4. Recent Development
- 11.19. Olink
- 11.19.1. Company Overview
- 11.19.2. Financial Performance
- 11.19.3. Product Benchmarking
- 11.19.4. Recent Development
- 11.20. DiaSorin S.p.A.
- 11.20.1. Company Overview
- 11.20.2. Financial Performance
- 11.20.3. Product Benchmarking
- 11.20.4. Recent Development
- 11.21. Antigenix America, Inc
- 11.21.1. Company Overview
- 11.21.2. Financial Performance
- 11.21.3. Product Benchmarking
- 11.21.4. Recent Development
- 11.22. Siemens Healthineers
- 11.22.1. Company Overview
- 11.22.2. Financial Performance
- 11.22.3. Product Benchmarking
- 11.22.4. Recent Development
- 11.23. PerkinElmer, Inc
- 11.23.1. Company Overview
- 11.23.2. Financial Performance
- 11.23.3. Product Benchmarking
- 11.23.4. Recent Development
- 11.24. Boster Biological Technology
- 11.24.1. Company Overview
- 11.24.2. Financial Performance
- 11.24.3. Product Benchmarking
- 11.24.4. Recent Development
- 11.25. Seegene
- 11.25.1. Company Overview
- 11.25.2. Financial Performance
- 11.25.3. Product Benchmarking
- 11.25.4. Recent Development
- 11.26. Cayman Chemical Company
- 11.26.1. Company Overview
- 11.26.2. Financial Performance
- 11.26.3. Product Benchmarking
- 11.26.4. Recent Development